SCHEDULE 13G: AllianceBernstein Discloses 5.2% Stake in Astera Labs Inc.

AllianceBernstein L.P. has filed a Schedule 13G, revealing a beneficial ownership of 5.2% in Astera Labs Inc.'s common stock as of March 31, 2025.

Summary

• AllianceBernstein L.P. reported beneficial ownership of 8,401,019 shares of Astera Labs Inc. common stock.
• This ownership represents 5.2% of the total class of Astera Labs Inc. common stock.
• The shares were acquired solely for investment purposes on behalf of client discretionary investment advisory accounts.
• AllianceBernstein L.P. holds sole voting power over 8,057,042 shares and sole dispositive power over 8,397,311 shares.
• Shared voting power is 0 shares, and shared dispositive power is 3,708 shares.
• The filing certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of Astera Labs Inc.

Sentiment

Score: 5

Explanation: The document is a factual disclosure of beneficial ownership, indicating a neutral sentiment. The investment itself could be seen as a positive signal, but the document's content is purely informational.

Positives

• A significant institutional investor, AllianceBernstein L.P., has taken a substantial 5.2% stake in Astera Labs Inc., which can be viewed as a vote of confidence in the company's prospects.

Future Outlook

This document, a Schedule 13G, is a disclosure of current beneficial ownership and does not contain forward-looking statements or guidance regarding Astera Labs Inc.'s future performance or outlook.

Management Comments

• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11." (Certification by Melissa Guerra, VP/Director of Compliance for AllianceBernstein L.P.)

Industry Context

This filing is a standard regulatory disclosure by a large investment adviser, AllianceBernstein L.P., indicating a significant passive investment in Astera Labs Inc. Such filings are common for institutional investors crossing the 5% beneficial ownership threshold, providing transparency to the market about major shareholdings.

Stakeholder Impact

• Shareholders: Provides transparency regarding a significant institutional holder, potentially influencing investor sentiment and trading activity.
• Company Management: Awareness of a large, passive institutional investor on their shareholder register.

Key Dates

Keywords

Astera Labs Inc., AllianceBernstein L.P., Schedule 13G, Beneficial Ownership, Common Stock, Investment Adviser, Institutional Holding, SEC Filing